Outcomes of Hypofractional Tomotherapy in Patients with Stage III Nonsmall Cell Lung Cancer Who Are Not Eligible for Surgery or Concurrent Chemoradiation

Table 4

Adverse effects after tomotherapy.

Adverse effects	Grade 1-2 (%)	Grade 3 (%)
Acute
Hematological toxicity	9 (20.93)	1 (2.32)
Fatigue	11 (25.58)	0
Esophagitis	8 (18.60)	0
Dermatitis	1 (2.32)	0
Pneumonia	7 (16.27)	0
<19 f	1 (2.32)	0
≥19 f	6 (13.95)	0
Late
Hematological toxicity	5 (11.63)	0
Fatigue	4 (9.30)	0
Esophagitis	1 (2.32)	0
Pneumonia	5 (11.63)	3 (6.98)
<19 f	2 (4.65)	0
≥19 f	3 (6.98)	3 (6.98)